A cancer survival rate, also called a survival statistic, is the percentage of people with a specific cancer who live for a set period after diagnosis. Researchers report a 5-year survival rate most of the time, which indicates how many patients live at least 5 years after doctors first identify the disease.
These percentages result from large studies that monitor hundreds or thousands of people with the same disease. To cite an example, the 5-year relative survival rate for localized breast cancer, or cancer that has not spread past the breast, is more than 99 percent. In simple terms, almost every woman diagnosed at that early stage lives 5 years or longer.
Most published rates refer to relative survival. A relative survival rate compares people who have a specific form of cancer to people in the general population of the same age and sex. A “99 percent relative survival rate” suggests the cancer group is 99 percent as likely to live 5 years as people in the general population.
What Is the Difference Between Relative and Observed Survival?
Relative survival compares cancer patients to the general population. It isolates the effect of the cancer alone. Most public statistics use this measure.
Observed survival counts every death from any cause, including cancer, heart disease, accidents, or old age.
Why Do Cancer Survival Statistics Use Five Years as a Reference Point?
Researchers adopted the 5-year survival rate because cancer registries required a consistent follow-up period to compare outcomes across hospitals, states, and decades. As discussed, for many cancers, the risk of recurrence is highest during the first three to five years after treatment, although some can recur much later.
What Are the Different Types of Survival Rates?
Oncologists refer to these rates to estimate a patient’s prognosis and decide between treatment options:
- All-stages or overall survival rate combines all stages of cancer, from early localized to advanced metastatic. It averages the outcomes of all patients with a given cancer.
- Stage-specific survival rate applies to one stage, which is more relevant to each patient’s case than a combined average.
- Disease-free survival rate counts patients with no trace of cancer after treatment ends.
- Progression-free survival rate applies to patients whose cancer has either disappeared or stabilized, neither growing nor spreading.
- Median survival considers the length of time at which half of patients are still living. Half live longer than the median, and many live far past it.
- Conditional survival is the likelihood of a cancer patient living for additional years, given that they have already survived a certain amount of time since their diagnosis.
No single survival rate can accurately predict an individual’s outcome. Instead, doctors consider multiple survival measures alongside the cancer type, stage at diagnosis, treatment response, and the patient’s overall health. To reiterate and set an example, a disease-free survival rate measures the percentage of people who remain cancer-free after initial treatment, while a conditional survival rate recalculates the chances of continued survival. Together, they give doctors a more individualized estimate for treatment planning, follow-up care, and long-term management.
How Do Doctors Estimate Survival Rates by Stage?
Stage describes how far cancer has spread. It affects survival odds as much as any other factor.
The SEER database by the National Cancer Institute groups cancers into three stages instead of the numbered stages many patients know.
- Localized cancer has not spread past the organ where it started.
- Regional cancer has invaded nearby tissues or lymph nodes.
- Distant cancer has reached organs far from where it initially developed, a process called metastasis.
Survival rates can differ significantly between stages. For breast cancer, localized disease has a 5-year relative survival above 99 percent, regional disease near 87 percent, and distant disease around 32 percent, according to the American Cancer Society in 2026. For lung cancer, localized non-small cell disease has a 34 percent five-year survival rate, while a distant case has 4 percent. These drastic differences emphasize the importance of early detection and routine screening.
The encouraging news is that survival for advanced cancer has improved in recent years. For all cancers combined, 5-year survival for distant-stage disease has doubled since the mid-1990s, from 17 percent to 35 percent. Advances in cancer treatment continue to improve outcomes for patients with advanced disease.
What Is the Difference Between a Prognosis and a Survival Rate?
The first question many people ask after a diagnosis is, “What’s my prognosis?” A prognosis is an estimate of how cancer is likely to progress based on survival rates and patient-specific clinical factors. It typically addresses:
- The chances of survival
- Whether signs and symptoms are likely to improve, remain stable, or worsen
- Expected quality of life before, during, and after treatment
- The risk of treatment-related or disease-related complications
- How well a specific type of cancer responds to treatment
Although no doctor can predict the future with absolute certainty, an experienced oncologist can provide a prognosis of the disease’s course and outcome. A survival rate is a specific statistical number used as part of that prognosis.
How Do Doctors Use Cancer Survival Statistics?
Survival data has two roles in cancer care:
1. Understanding Prognosis
Survival rates help oncologists estimate the likely course of a patient’s disease by comparing it with outcomes in patients who have a similar cancer type, stage, age, overall health, and other clinical characteristics. These comparisons also help estimate the likelihood of remission and long-term survival.
2. Planning Treatment
Survival data represents how patients with a particular cancer type and stage have responded to different treatments. Oncologists combine this information with the patient’s diagnosis, overall health, goals, and personal preferences when recommending a treatment plan. If two therapies offer similar chances of remission but one has a lower risk of side effects, it may be the more appropriate choice for preserving quality of life.
What Can’t Cancer Survival Rates Tell You?
Survival statistics have limitations. Understanding them keeps the numbers in perspective.
- They refer to groups, not individuals. Survival rates summarize the experiences of large groups of patients. They cannot predict an individual patient’s outcome with certainty, as factors including cancer biology, age, general health, and treatment response, among other clinical data, vary from person to person.
- They lag behind current medicine. Patients counted in today’s 5-year statistics received their diagnosis at least 5 years ago. Recent breakthroughs will not appear in the data for years to come, underestimating outcomes for patients treated with newer therapies.
- They combine early and late diagnoses. All-stages survival rates, as mentioned earlier, merge data from patients with localized, regional, and distant disease. Since early-stage cancers often have much higher survival rates than advanced cancers, the overall figure does not estimate prognosis for a specific stage.
For these reasons, some patients choose not to dwell on survival percentages.
What Does It Mean When Doctors Call a Cancer “Cured”?
Oncologists use the word “cure” with caution. For instance, being cancer-free for five years after treatment is associated with a low risk of recurrence. In such cases, doctors may consider the cancer cured. However, certain cancers can recur after 5 years or longer.
Patients will hear related terms during follow-up appointments:
- Complete remission. Tests and imaging detect no cancer.
- Partial remission. Some cancer persists, but the tumor burden has shrunk significantly.
- No evidence of disease (NED). Scans, blood work, and physical examination detect no signs of cancer.
Our complete guide to cancer remission terminology explains NED, nCR, and other abbreviations commonly mentioned in radiology and pathology reports.
What Factors Affect Cancer Survival?
Oncologists evaluate several clinical characteristics when estimating outcomes and developing a treatment plan.
- Exact cancer type. Each form of cancer has distinct biological characteristics, patterns of growth, and expected treatment response.
- Stage at diagnosis. The extent of cancer at the time of diagnosis is a leading predictor of prognosis. In general, cancers detected before they have spread are associated with more favorable outcomes.
- Tumor grade. Tumor grade classifies cancer cells according to how they appear under a microscope. Higher-grade tumors often grow and spread more rapidly than lower-grade tumors.
- Molecular and genetic features. Biomarkers, genetic mutations, and other molecular characteristics help determine prognosis and eligibility for immunotherapies, targeted therapies, and other precision treatments.
- Coexisting illness. Diabetes, cardiovascular disease, and kidney disease, to name a few chronic conditions, restrict treatment options and shorten survival independent of the cancer itself.
- Response to treatment. How well a cancer responds to treatment helps doctors evaluate whether the current approach is working, or whether additional or alternative treatments are appropriate.
- Nutritional status. Malnutrition and sarcopenia, the loss of skeletal muscle mass, reduce treatment tolerance and survival. One prospective cohort of 403 lung cancer patients found median overall survival of 13.2 months among sarcopenic patients versus 43.3 months among those with preserved muscle mass. Our article on malnutrition in cancer patients explains why nutritional support must be in every treatment plan, and our guide to protein intake during treatment covers specific targets.
- Access to treatment. Uninsured individuals diagnosed with stage I colorectal cancer had lower five-year survival than privately insured patients with stage II disease. Insurance coverage and treatment delays change outcomes as much as some biological variables. Our article on the high cost of cancer care in the United States covers treatment barriers and what patients can do about them.
- Lifestyle and supportive care. Regular physical activity, smoking cessation, and access to supportive care can improve treatment tolerance, symptom management, and quality of life.
- Age. Older adults may have other medical conditions or reduced kidney, liver, or heart function, which can affect treatment options and recovery.
Because these factors vary per patient, individuals with the same type and stage of cancer may have different prognoses and treatment outcomes.
How Have Cancer Survival Rates Improved Over Time?
The increase in 5-year survival across all cancers exhibits decades of progress in early detection and treatment. Several advances have driven this change.
- Earlier detection. Screening programs identify breast, colon, cervical, and lung cancers before symptoms appear, when treatment works best.
- Immunotherapy. These treatments train the immune system to recognize and kill cancer cells. Learn how it compares to targeted therapy.
- Precision oncology. Oncologists match therapies to the genetic profile of a tumor, which improves response rates and reduces time spent on treatments unlikely to help. Read more about precision oncology.
Survival has improved for several cancers that once had very poor prognoses. For instance, the 5-year survival for myeloma increased from 32 percent to 62 percent, and liver cancer survival rose from 7 percent to 22 percent. Although these cancers are still challenging to treat, ongoing advances continue to improve long-term survival.
Stories of Hope From Our Patients
Survival rates help patients and physicians understand outcomes across large populations, but they do not apply equally to everyone. Every diagnosis, treatment plan, and response to therapy is unique.
Many patients have shared their experiences after receiving care at New Hope Unlimited. Breast cancer survivor Cynthia Kicklighter recalled her journey, saying, “If we give our body the right things, cancer is not something to fear. There is no situation that is hopeless.”
Laura Hilton also shared her family’s experience after her husband, Barry, received treatment at New Hope Unlimited. She credited the education, support, and care they received throughout his treatment and reported that Barry became cancer-free.
Another patient, a 46-year-old woman, had a grade 2/3 transitional cell carcinoma of the bladder with muscle invasion. Two of seven pelvic lymph nodes contained metastatic disease, and surgeons aborted her planned cystectomy. After seeking treatment at New Hope Unlimited, her subsequent CT scans of the abdomen and pelvic area have continued to show no evidence of metastatic disease.
Disclaimer: These stories highlight individual patient experiences and should not be interpreted as typical results. How well the body responds to treatment varies from patient to patient, even among those with similar diagnoses, because each person’s internal makeup differs.
Additional patient testimonials are available for those interested in learning more about New Hope Unlimited.
Personalized Cancer Care at New Hope Unlimited
New Hope Unlimited develops individualized treatment plans for more than 200 types of cancer, including lung, colorectal, breast, prostate, pancreatic, liver, and several rare malignancies. Each treatment plan considers the cancer type, stage, grade, molecular characteristics, symptoms, previous treatments, and the patient’s overall health.
More specifically, care at our treatment center may include:
- Conventional, integrative, and complementary therapies selected according to the patient’s diagnosis and treatment goals.
- Advanced treatment options, including immunotherapy, targeted therapy, and other evidence-based approaches.
- Nutritional support, symptom management, rehabilitation, and other supportive services throughout treatment and recovery.
- Coordinated care from physicians and specialists with expertise in over 200 cancer types.
The goal of every treatment plan is to pursue remission whenever possible while preserving or improving quality of life.
Let’s Discuss Your Treatment Options
A cancer diagnosis might change your life, but it does not define your future. Survival statistics have improved across almost every cancer type, and many cancers found early respond well to modern treatments. Advances in cancer treatment have even improved outcomes for patients with metastatic disease, helping many live longer while maintaining a good quality of life.
If you have cancer, or you are researching treatments for a loved one, let New Hope Unlimited guide you toward precision oncology. Schedule a consultation or call 480-666-1403 to speak with our team.
FAQs About Cancer Survival Rates
What is a five-year survival rate?
A five-year survival rate is the percentage of cancer patients who live at least five years after their diagnosis. Most published figures use relative survival, which compares patients against people of the same age, sex, and race who do not have cancer. Note that the five-year mark is a research convention, not a medical deadline.
Does a 70% survival rate mean I have a 70% chance of surviving?
No. That figure describes everyone diagnosed with any cancer at any stage from 2015 through 2021, treated with the therapies available at that time. Your personal outlook varies based on your cancer type, stage, tumor grade, molecular profile, age, coexisting conditions, and the treatments available to you today.
Can cancer come back after five years?
Yes. Most recurrences happen within the first three to five years, though late recurrences are also possible. For example, in some documented cases, breast cancer has returned more than 20 years after initial remission. With that said, ongoing follow-up care is important even after a patient achieves NED.
What is the difference between remission and cure?
Doctors use the term remission when cancer responds to treatment. In complete remission, tests and examinations find no evidence of disease, while partial remission indicates that the cancer has shrunk but remains detectable. A cure means the cancer is not expected to return, although no doctor can say so with complete certainty. For some cancers, five years without recurrence may justify describing the cancer as cured, but no single timeframe applies to every cancer type.
Do I have to know my survival statistics?
No. You have every right to decline this information. Tell your doctor at the start of your appointment that you prefer to discuss your treatment plan without the percentages.